Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.40 |
| ▸ | KCNA5 | P22460 | 4/20 | 0.40 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2486157 | 0.98 | CYP3A4 (0.39) | CYP3A4CYP2C9CYP2C19KCNH2CYP1A2 | |
| Hydrochloric Acid SCHEMBL28024977 | 0.95 | CYP3A4 (0.38) | CYP3A4CYP2C9CYP2C19KCNH2CYP1A2 | |
| SCHEMBL11661164 | 0.92 | CYP3A4 (0.35) | CYP3A4CYP2C9CYP2C19KCNH2CYP1A2 | |
| SCHEMBL11679532 | 0.89 | CYP3A4 (0.33) | CYP3A4CYP2C9CYP2C19KCNH2CYP1A2 | |
| SCHEMBL14966049 | 0.87 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19KCNH2CYP1A2 | |
| SCHEMBL6901641 | 0.81 | KCNH2 (0.41) | CYP3A4CYP2C9CYP2C19KCNH2CYP1A2 | |
| SCHEMBL11679024 | 0.78 | CYP3A4 (0.39) | CYP3A4CYP2C9CYP2C19KCNH2CYP1A2 | |
| SCHEMBL20091551 | 0.77 | LMNA (0.48) | CYP2C9CYP2C19TSHRSIGMAR1ALDH1A1 | |
| SCHEMBL11570649 | 0.77 | SIGMAR1 (0.48) | TSHRSIGMAR1HPGDALDH1A1SLC6A3 | |
| SCHEMBL16775636 | 0.76 | SIGMAR1 (0.47) | TSHRSIGMAR1HPGDALDH1A1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109776303-A | It is used to prepare the catalyst of acrylic acid or derivatives thereof | 重庆化工职业学院 | 2019-05-21 | — | — | CN | claimed |
| US-11779912-B2 | Synthesis and characterization of Ru alkylidene complexes | UMICORE AG & CO. KG (DE) | 2023-10-10 | — | — | US | disclosed |
| US-11779912-B2 | Synthesis and characterization of Ru alkylidene complexes | UMICORE AG & CO. KG (DE) | 2023-10-10 | — | — | US | disclosed |
| US-11779912-B2 | Synthesis and characterization of Ru alkylidene complexes | UMICORE AG & CO. KG (DE) | 2023-10-10 | — | — | US | disclosed |
| CN-114106057-B | Synthesis and characterization of Ru alkylene complexes | 优美科股份公司及两合公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-109862963-B | Synthesis and characterization of Ru alkylidene complexes | 优美科股份公司及两合公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-114106057-A | Synthesis and characterization of Ru alkylidene complexes | 优美科股份公司及两合公司 | 2022-03-01 | — | — | CN | disclosed |
| US-20210394167-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | UMICORE AG & CO. KG (DE) | 2021-12-23 | — | — | US | disclosed |
| US-20210394167-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | UMICORE AG & CO. KG (DE) | 2021-12-23 | — | — | US | disclosed |
| US-11123722-B2 | Synthesis and characterization of Ru alkylidene complexes | UMICORE AG & CO. KG | 2021-09-21 | — | — | US | disclosed |
| US-11123722-B2 | Synthesis and characterization of Ru alkylidene complexes | UMICORE AG & CO. KG | 2021-09-21 | — | — | US | disclosed |
| EP-3528942-B1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | UMICORE AG & CO KG (DE) | 2021-04-28 | — | — | EP | disclosed |
| EP-3528942-B1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | UMICORE AG & CO KG (DE) | 2021-04-28 | — | — | EP | disclosed |
| US-20200330970-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | UMICORE AG & CO. KG (DE) | 2020-10-22 | — | — | US | disclosed |
| US-20200330970-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | UMICORE AG & CO. KG (DE) | 2020-10-22 | — | — | US | disclosed |
| US-10792651-B2 | Synthesis and characterization of Ru alkylidene complexes | UMICORE AG & CO. KG (DE) | 2020-10-06 | — | — | US | disclosed |
| US-10792651-B2 | Synthesis and characterization of Ru alkylidene complexes | UMICORE AG & CO. KG (DE) | 2020-10-06 | — | — | US | disclosed |
| US-20200038851-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | UMICORE AG & CO. KG (DE) | 2020-02-06 | — | — | US | disclosed |
| US-20200038851-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | UMICORE AG & CO. KG (DE) | 2020-02-06 | — | — | US | disclosed |
| WO-2018075479-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | MATERIA, INC. (US) | 2018-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210394167-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | PORCN, ORC3, COASY | CYP3A4 137/4885CYP2C9 889/4885CYP2C19 774/4885 |
| US-20200330970-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | PORCN, ORC3, COASY | CYP3A4 137/4885CYP2C9 889/4885CYP2C19 774/4885 |
| US-20200038851-A1 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | PORCN, ORC3, COASY | CYP3A4 137/4885CYP2C9 889/4885CYP2C19 774/4885 |
| US-11779912-B2 | Synthesis and characterization of Ru alkylidene complexes | PORCN, ORC3, COASY | CYP3A4 137/4885CYP2C9 889/4885CYP2C19 774/4885 |
| US-11123722-B2 | Synthesis and characterization of Ru alkylidene complexes | PORCN, ORC3, COASY | CYP3A4 137/4885CYP2C9 889/4885CYP2C19 774/4885 |
| US-10792651-B2 | Synthesis and characterization of Ru alkylidene complexes | PORCN, ORC3, COASY | CYP3A4 137/4885CYP2C9 889/4885CYP2C19 774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.